Home › Cancro alla prostata › Delaware › Newark
Studi clinici su Cancro alla prostata a Newark, DE
10 studi su Cancro alla prostata cercano partecipanti presso sedi a Newark e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
In reclutamentoFase 1/2
- Medical Oncology Hematology Consultants, Newark
Testing Different Dosing Schedules of the Anti-cancer Drug, Lutetium 177Lu PSMA RLT and Its Effect on Patients With Advanced Prostate Cancer, RECIPROCAL Trial
In reclutamentoFase 3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
Targeted Treatment for Metastatic Prostate Cancer, The PREDICT Trial
In reclutamentoFase 2
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
A Study of Xaluritamig Plus Abiraterone Versus Investigator's Choice in Participants With Chemotherapy-naïve Metastatic Castration-resistant Prostate Cancer
In reclutamentoFase 3
- Medical Oncology Hematology Consultants Helen F Graham Cancer Center, Newark
Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer
In reclutamentoFase 3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
Docetaxel to Androgen Receptor Pathway Inhibitors in Patients With Metastatic Castration Sensitive Prostate Cancer and Suboptimal PSA Response
In reclutamentoFase 3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
- Christiana Care Health System-Christiana Hospital, Newark
- e altri 1
Testing Whether the Addition of Carboplatin Chemotherapy to Cabazitaxel Chemotherapy Will Improve Outcomes Compared to Cabazitaxel Alone in People With Castrate-Resistant Prostate Cancer That Has Spread Beyond the Prostate to Other Parts of the Body
In reclutamentoFase 3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
- Christiana Care Health System-Christiana Hospital, Newark
- e altri 1
Vitamin D for Prostate Endocrine Therapy
In reclutamentoFase 3
- Helen F Graham Cancer Center, Newark
- Medical Oncology Hematology Consultants PA, Newark
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Newark
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
In reclutamentoFase 3
- Helen F Graham Cancer Center, Newark
- Christiana Care Health System-Christiana Hospital, Newark
Studi su Cancro alla prostata in altre città
- New York City, NY103 studi
- Houston, TX76 studi
- Los Angeles, CA61 studi
- Boston, MA59 studi
- St. Louis, MO46 studi
- Chicago, IL45 studi
- San Francisco, CA45 studi
- Philadelphia, PA44 studi
- Baltimore, MD43 studi
- Nashville, TN42 studi
- Seattle, WA42 studi
- Washington, DC38 studi
Altri studi a Newark
- Cancro del polmone non a piccole cellule16 studi
- Cancro colorettale9 studi
- Cancro ai polmoni9 studi
- Cancro al seno8 studi
- Cancro metastatico7 studi
- Cancro (tutti i tipi)6 studi
- Cancro pancreatico6 studi
- Cancro ovarico5 studi
- Linfoma follicolare4 studi
- Leucemia linfatica cronica4 studi
- Cancro dello stomaco4 studi
- Melanoma4 studi
Fonte: ClinicalTrials.gov, dati recuperati il 5 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.